The Apolipoprotein E2(Arg145Cys) Mutation Causes Autosomal Dominant Type III Hyperlipoproteinemia With Incomplete Penetrance

Abstract excerpt

Type III hyperlipoproteinemia (type III HLP) is an atherogenic disorder of lipoprotein metabolism characterized by the accumulation of cholesterol-enriched VLDL and is usually associated with homozygosity for a normal variant of apoE, apoE2. ApoE2(Arg145Cys) is a rare variant arising from a C-->T transition at nucleotide 4031 and has been linked to type III HLP. Ten subjects from a group of 42 unrelated...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Diabetes, Cardiovascular Risks, and Lipoproteins
• Share to Lipoproteins and Cardiovascular Health
• Share to Protein Kinase Regulation and GTPase Signaling